Kenneth Knecht
Concepts (177)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Transplantation | 20 | 2022 | 272 | 4.000 |
Why?
| Graft Rejection | 10 | 2022 | 149 | 2.020 |
Why?
| Heart Failure | 5 | 2020 | 492 | 0.990 |
Why?
| Cardiomyopathy, Dilated | 3 | 2023 | 37 | 0.880 |
Why?
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 50 | 0.780 |
Why?
| Tissue Donors | 6 | 2022 | 105 | 0.730 |
Why?
| Cerebrovascular Circulation | 2 | 2010 | 144 | 0.710 |
Why?
| Down Syndrome | 2 | 2022 | 100 | 0.700 |
Why?
| Child | 26 | 2022 | 7232 | 0.690 |
Why?
| Child, Preschool | 18 | 2023 | 4129 | 0.680 |
Why?
| Adolescent | 22 | 2022 | 6918 | 0.630 |
Why?
| Muscular Dystrophy, Duchenne | 3 | 2022 | 15 | 0.590 |
Why?
| Cardiomyopathy, Hypertrophic | 1 | 2016 | 37 | 0.580 |
Why?
| Athletes | 1 | 2016 | 113 | 0.560 |
Why?
| Myocarditis | 3 | 2021 | 40 | 0.530 |
Why?
| Telangiectasia, Hereditary Hemorrhagic | 1 | 2013 | 8 | 0.500 |
Why?
| Heart-Assist Devices | 5 | 2021 | 147 | 0.490 |
Why?
| Carbon Monoxide | 2 | 2010 | 37 | 0.490 |
Why?
| Renal Insufficiency | 1 | 2014 | 138 | 0.480 |
Why?
| Leukemia, Myeloid, Acute | 1 | 2015 | 182 | 0.480 |
Why?
| Cardiomyopathies | 3 | 2021 | 111 | 0.480 |
Why?
| Receptors, Cell Surface | 1 | 2013 | 137 | 0.460 |
Why?
| Heart Defects, Congenital | 4 | 2022 | 598 | 0.440 |
Why?
| Antigens, CD | 1 | 2013 | 230 | 0.440 |
Why?
| Natriuretic Peptide, Brain | 1 | 2012 | 25 | 0.430 |
Why?
| Atrial Septum | 1 | 2011 | 3 | 0.430 |
Why?
| Heart Rupture | 1 | 2011 | 10 | 0.430 |
Why?
| Central Nervous System Stimulants | 1 | 2014 | 254 | 0.420 |
Why?
| Heart Septal Defects, Atrial | 1 | 2011 | 45 | 0.410 |
Why?
| Humans | 36 | 2023 | 53836 | 0.400 |
Why?
| Peptide Fragments | 1 | 2012 | 258 | 0.390 |
Why?
| Pia Mater | 1 | 2010 | 4 | 0.390 |
Why?
| Donor Selection | 2 | 2020 | 13 | 0.380 |
Why?
| Vasoconstriction | 1 | 2010 | 59 | 0.380 |
Why?
| Male | 24 | 2022 | 27633 | 0.370 |
Why?
| Vasoconstrictor Agents | 1 | 2010 | 87 | 0.370 |
Why?
| Angiotensin II | 1 | 2010 | 168 | 0.360 |
Why?
| Infant | 12 | 2021 | 3765 | 0.360 |
Why?
| Vasodilation | 1 | 2010 | 105 | 0.360 |
Why?
| Reoperation | 1 | 2011 | 464 | 0.360 |
Why?
| Auscultation | 1 | 2009 | 9 | 0.350 |
Why?
| Kidney | 1 | 2014 | 828 | 0.350 |
Why?
| Cardiovascular Diseases | 1 | 2014 | 477 | 0.350 |
Why?
| Blood Pressure Determination | 1 | 2009 | 53 | 0.350 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1049 | 0.340 |
Why?
| Retrospective Studies | 15 | 2022 | 6330 | 0.330 |
Why?
| Echocardiography, Transesophageal | 2 | 2023 | 73 | 0.330 |
Why?
| Cardiac Surgical Procedures | 1 | 2011 | 318 | 0.320 |
Why?
| Gene Expression Profiling | 1 | 2013 | 1138 | 0.320 |
Why?
| Waiting Lists | 4 | 2022 | 46 | 0.300 |
Why?
| Female | 21 | 2023 | 28727 | 0.290 |
Why?
| Infant, Newborn | 6 | 2020 | 2862 | 0.280 |
Why?
| Ventricular Function, Left | 2 | 2019 | 175 | 0.280 |
Why?
| Fontan Procedure | 2 | 2021 | 56 | 0.250 |
Why?
| Isoantibodies | 2 | 2013 | 33 | 0.220 |
Why?
| HLA Antigens | 2 | 2013 | 54 | 0.220 |
Why?
| Dystrophin | 1 | 2022 | 5 | 0.220 |
Why?
| Graft Survival | 3 | 2020 | 160 | 0.210 |
Why?
| Odds Ratio | 2 | 2014 | 613 | 0.210 |
Why?
| Ventricular Dysfunction, Right | 1 | 2022 | 32 | 0.210 |
Why?
| Arterioles | 2 | 2010 | 36 | 0.200 |
Why?
| Tissue and Organ Procurement | 1 | 2020 | 38 | 0.180 |
Why?
| Risk Factors | 8 | 2021 | 3958 | 0.180 |
Why?
| Models, Statistical | 1 | 2021 | 257 | 0.180 |
Why?
| Ventricular Dysfunction, Left | 1 | 2020 | 94 | 0.180 |
Why?
| Cardiopulmonary Resuscitation | 2 | 2020 | 130 | 0.180 |
Why?
| Animals, Newborn | 2 | 2010 | 405 | 0.180 |
Why?
| Consensus | 1 | 2020 | 154 | 0.170 |
Why?
| Defibrillators, Implantable | 1 | 2020 | 63 | 0.170 |
Why?
| Myocardium | 2 | 2019 | 441 | 0.170 |
Why?
| Swine | 2 | 2010 | 482 | 0.170 |
Why?
| Diagnosis, Differential | 2 | 2013 | 1139 | 0.170 |
Why?
| Extracorporeal Membrane Oxygenation | 3 | 2019 | 300 | 0.170 |
Why?
| Treatment Outcome | 9 | 2022 | 5645 | 0.160 |
Why?
| Ventricular Dysfunction | 1 | 2017 | 10 | 0.160 |
Why?
| Defibrillators | 1 | 2016 | 9 | 0.150 |
Why?
| Severity of Illness Index | 1 | 2021 | 1087 | 0.150 |
Why?
| Electric Countershock | 1 | 2016 | 33 | 0.150 |
Why?
| Out-of-Hospital Cardiac Arrest | 1 | 2016 | 28 | 0.150 |
Why?
| Hospitalization | 1 | 2021 | 687 | 0.140 |
Why?
| Follow-Up Studies | 4 | 2019 | 2376 | 0.140 |
Why?
| Prospective Studies | 3 | 2021 | 2569 | 0.140 |
Why?
| Age of Onset | 1 | 2015 | 119 | 0.130 |
Why?
| Body Surface Area | 1 | 2014 | 23 | 0.130 |
Why?
| Age Factors | 3 | 2021 | 1217 | 0.130 |
Why?
| Steroids | 1 | 2015 | 55 | 0.130 |
Why?
| Kidney Function Tests | 1 | 2014 | 62 | 0.130 |
Why?
| Risk Assessment | 1 | 2020 | 1375 | 0.130 |
Why?
| Creatinine | 1 | 2014 | 173 | 0.130 |
Why?
| Glomerular Filtration Rate | 1 | 2014 | 139 | 0.130 |
Why?
| Tachycardia | 1 | 2014 | 32 | 0.120 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 150 | 0.120 |
Why?
| Polysomnography | 1 | 2013 | 73 | 0.120 |
Why?
| Cardiovascular Abnormalities | 1 | 2013 | 26 | 0.120 |
Why?
| Methylphenidate | 1 | 2014 | 97 | 0.120 |
Why?
| Echocardiography | 3 | 2022 | 374 | 0.120 |
Why?
| Regression Analysis | 1 | 2014 | 462 | 0.120 |
Why?
| Vena Cava, Inferior | 1 | 2013 | 79 | 0.120 |
Why?
| Adult | 7 | 2022 | 14303 | 0.110 |
Why?
| Immunosuppressive Agents | 1 | 2014 | 249 | 0.110 |
Why?
| Registries | 1 | 2015 | 548 | 0.110 |
Why?
| Young Adult | 4 | 2020 | 4356 | 0.110 |
Why?
| Embolization, Therapeutic | 1 | 2013 | 98 | 0.110 |
Why?
| Time Factors | 3 | 2021 | 3282 | 0.110 |
Why?
| Heart Ventricles | 1 | 2014 | 268 | 0.110 |
Why?
| Echocardiography, Doppler, Color | 1 | 2011 | 29 | 0.110 |
Why?
| Suture Techniques | 1 | 2011 | 74 | 0.100 |
Why?
| Cardiac Catheterization | 1 | 2013 | 240 | 0.100 |
Why?
| Endothelium-Dependent Relaxing Factors | 1 | 2010 | 4 | 0.100 |
Why?
| Nitric Acid | 1 | 2010 | 5 | 0.100 |
Why?
| Proteasome Inhibitors | 1 | 2012 | 110 | 0.100 |
Why?
| Prostaglandins | 1 | 2010 | 19 | 0.100 |
Why?
| Boronic Acids | 1 | 2012 | 197 | 0.100 |
Why?
| Pyrazines | 1 | 2012 | 201 | 0.100 |
Why?
| Nitroprusside | 1 | 2010 | 11 | 0.100 |
Why?
| Potassium Channels, Calcium-Activated | 1 | 2010 | 5 | 0.100 |
Why?
| Feedback, Physiological | 1 | 2010 | 19 | 0.100 |
Why?
| Isoproterenol | 1 | 2010 | 55 | 0.100 |
Why?
| Genetic Predisposition to Disease | 1 | 2013 | 578 | 0.090 |
Why?
| Nitric Oxide Synthase | 1 | 2010 | 102 | 0.090 |
Why?
| Vasodilator Agents | 1 | 2010 | 108 | 0.090 |
Why?
| Diastole | 1 | 2009 | 77 | 0.090 |
Why?
| Cause of Death | 2 | 2020 | 154 | 0.090 |
Why?
| Cardiotonic Agents | 2 | 2020 | 79 | 0.090 |
Why?
| Systole | 1 | 2009 | 77 | 0.090 |
Why?
| Logistic Models | 1 | 2012 | 1002 | 0.090 |
Why?
| Endothelium, Vascular | 1 | 2010 | 287 | 0.080 |
Why?
| Arginine | 1 | 2010 | 183 | 0.080 |
Why?
| Reference Values | 1 | 2009 | 378 | 0.080 |
Why?
| Tomography, X-Ray Computed | 1 | 2013 | 1204 | 0.080 |
Why?
| Nitric Oxide | 1 | 2010 | 301 | 0.080 |
Why?
| Electrocardiography | 2 | 2020 | 286 | 0.080 |
Why?
| Dose-Response Relationship, Drug | 1 | 2010 | 1518 | 0.070 |
Why?
| Survival Rate | 2 | 2021 | 974 | 0.070 |
Why?
| Ipratropium | 1 | 2005 | 1 | 0.070 |
Why?
| Albuterol | 1 | 2005 | 58 | 0.060 |
Why?
| Bronchodilator Agents | 1 | 2005 | 74 | 0.060 |
Why?
| Animals | 2 | 2010 | 14624 | 0.060 |
Why?
| Cohort Studies | 2 | 2022 | 1548 | 0.060 |
Why?
| Databases, Factual | 2 | 2016 | 696 | 0.060 |
Why?
| Aorta | 1 | 2023 | 183 | 0.050 |
Why?
| Incidence | 2 | 2015 | 1074 | 0.050 |
Why?
| Asthma | 1 | 2005 | 278 | 0.050 |
Why?
| Ventricular Function, Right | 1 | 2022 | 44 | 0.050 |
Why?
| Prognosis | 2 | 2019 | 2115 | 0.050 |
Why?
| Protein-Losing Enteropathies | 1 | 2021 | 4 | 0.050 |
Why?
| Treatment Failure | 1 | 2021 | 141 | 0.050 |
Why?
| Warm Ischemia | 1 | 2020 | 4 | 0.050 |
Why?
| Cold Ischemia | 1 | 2020 | 12 | 0.050 |
Why?
| Troponin | 1 | 2020 | 15 | 0.050 |
Why?
| Hemodynamics | 1 | 2021 | 257 | 0.050 |
Why?
| Troponin I | 1 | 2019 | 20 | 0.040 |
Why?
| ROC Curve | 1 | 2019 | 262 | 0.040 |
Why?
| Longitudinal Studies | 1 | 2021 | 744 | 0.040 |
Why?
| Chest Pain | 1 | 2019 | 66 | 0.040 |
Why?
| Anti-Arrhythmia Agents | 1 | 2019 | 86 | 0.040 |
Why?
| Disease Progression | 1 | 2022 | 911 | 0.040 |
Why?
| RNA, Messenger | 1 | 2021 | 1276 | 0.040 |
Why?
| Biopsy | 1 | 2019 | 679 | 0.040 |
Why?
| Respiration, Artificial | 1 | 2019 | 281 | 0.040 |
Why?
| Mutation | 1 | 2022 | 1425 | 0.030 |
Why?
| Propensity Score | 1 | 2015 | 136 | 0.030 |
Why?
| Survival Analysis | 1 | 2016 | 746 | 0.030 |
Why?
| Drug Administration Schedule | 1 | 2015 | 411 | 0.030 |
Why?
| Azygos Vein | 1 | 2013 | 12 | 0.030 |
Why?
| Coronary Circulation | 1 | 2013 | 60 | 0.030 |
Why?
| Kaplan-Meier Estimate | 1 | 2015 | 517 | 0.030 |
Why?
| Aged | 1 | 2019 | 10151 | 0.020 |
Why?
| Respiratory Function Tests | 1 | 2005 | 100 | 0.020 |
Why?
| Drug Combinations | 1 | 2005 | 129 | 0.020 |
Why?
| Administration, Inhalation | 1 | 2005 | 119 | 0.020 |
Why?
| Emergency Medicine | 1 | 2005 | 60 | 0.020 |
Why?
| Nebulizers and Vaporizers | 1 | 2005 | 58 | 0.020 |
Why?
| United States | 1 | 2015 | 5162 | 0.020 |
Why?
| Acute Disease | 1 | 2005 | 407 | 0.020 |
Why?
| Middle Aged | 1 | 2019 | 13217 | 0.020 |
Why?
| Pediatrics | 1 | 2005 | 327 | 0.010 |
Why?
|
|
Knecht's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|